4//SEC Filing
Maccecchini Maria-Luisa 4
Accession 0001104659-24-077834
CIK 0001477845other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:16 PM ET
Size
13.3 KB
Accession
0001104659-24-077834
Insider Transaction Report
Form 4
Maccecchini Maria-Luisa
DirectorPresident & CEO
Transactions
- Gift
Common Stock
2024-03-31−10,000→ 1,068,459 total - Award
Stock Option (right to buy)
2023-11-17+252,000→ 252,000 totalExercise: $6.07Exp: 2033-11-17→ Common Stock (252,000 underlying) - Award
Stock Option (right to buy)
2023-11-17+108,800→ 108,800 totalExercise: $6.07Exp: 2033-11-17→ Common Stock (108,800 underlying) - Gift
Common Stock
2024-03-28−10,000→ 1,088,459 total - Gift
Common Stock
2024-03-31−10,000→ 1,078,459 total
Footnotes (5)
- [F1]Represents charitable gifts donated by the reporting person. No proceeds were received by the reporting person.
- [F2]On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved.
- [F3]Stock option will vest in eight consecutive quarterly installments of 31,500 shares each on the 17th day of February, May, August and November of each year, continuing through November 17, 2025.
- [F4]The stock option was granted in lieu of cash payment for 2023 fiscal year bonus. 100% of the stock option grant listed was also contingent upon the aforementioned amendment to the 2019 Equity Incentive Plan to increase the number of issuable shares from 2,000,000 to 3,000,000. It would have been forfeited if the amendment had not been approved.
- [F5]The stock option shall vest immediately.
Documents
Issuer
Annovis Bio, Inc.
CIK 0001477845
Entity typeother
Related Parties
1- filerCIK 0001315018
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:16 PM ET
- Size
- 13.3 KB